Richard Krasuski, MD
Cardiovascular Disease · Cleveland, OHNPI 1205921954
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Medtronic at 41.6% of the total. Among cardiovascular disease clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 161 payments — averaging $485.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$32K
- W. L. Gore & Associates, Inc.$16K
- Actelion Pharmaceuticals US, Inc.$12K
- Bayer$7K
- Actelion Pharmaceuticals, Ltd$6K
- Edwards Lifesciences$3K
- plus $2K from 2 others
Across 18 payments — averaging $9132.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$121K
- Insmed, Inc.$43K
What the payments were for
- Consulting fees$37,66048%
- Speaking & faculty fees$23,70930%
- Travel & lodging$11,09014%
- Food & beverage$5,7407%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 84 | $32,498 |
| W. L. Gore & Associates, Inc. | 9 | $16,405 |
| Actelion Pharmaceuticals US, Inc. | 34 | $12,125 |
| Bayer | 3 | $6,962 |
| Actelion Pharmaceuticals, Ltd | 1 | $5,890 |
| Edwards Lifesciences | 16 | $2,818 |
| Artivion, Inc. | 5 | $1,008 |
| United Therapeutics Corporation | 9 | $503 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HARMONY$29,075
- GORE CARDIOFORM Septal Occluder$16,233
- Adempas$6,962
- OPSUMIT$3,976
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,854
- CoreValve Evolut$1,022
- On-X$827
- THE EDWARDS SAPIEN 3 VALVE WITH ALTERRA ADAPTIVE PRESTENT SYSTEM$443
- BOSENTAN$428
- UPTRAVI$256
- SynerGraft$118
How this compares
$78,210 in reported general payments places this provider in the 95th percentile of 827 cardiovascular disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 26 | $29,551 |
| Torsemide | 23 | $641 |
| Metoprolol Succinate | 29 | $486 |
| Spironolactone | 32 | $356 |
| Lisinopril | 11 | $7 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Cleveland
- Guilherme AttizzaniCleveland$1.3M
- Abraham LincoffCleveland$369K
- Oussama WazniCleveland$367K
- Ian NeelandCleveland$329K
- Mazen HannaCleveland$208K
- Brian HoitCleveland$207K
- Steven NissenCleveland$149K
- Daniel CantillonCleveland$140K
- Serge HarbCleveland$134K
- Wael JaberCleveland$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.